India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
SCIENTISTS FIND A BLOOD TEST THAT PREDICTS LUNG CANCER YEARS EARLY Why in the News? Major Discovery: Scientists led by the Francis Crick Institute, London identified a 14-protein signature in blood plasma that can predict lung cancer years before diagnosis. Published Study: The findings were published in the journal Cell and were based on data …
Read MoreINDIA NEEDS INNOVATIVE STRATEGIES TO ELIMINATE TB Syllabus: GS 2: Issues related to the Social sector : Health care. Government policies and interventions. Why in the News? India’s fight against Tuberculosis (TB) has gained momentum following encouraging results from the PreVenTB Trial, which demonstrated significant efficacy of indigenous vaccines against extrapulmonary TB. The findings …
Read MoreIndian Antibiotic Innovation Reaches Global Healthcare Stage Syllabus: GS-2: Health, Important International Institutions GS-3:Government Policies & Interventions Why in the News ? The novel antibiotic Zaynich recently received approval from the U.S. Food and Drug Administration (FDA), marking a significant milestone for India’s pharmaceutical innovation ecosystem. The achievement highlights India’s growing capability in drug discovery …
Read MoreINDIA’S FIRST ALZHEIMER’S DISEASE-MODIFYING THERAPY Why in the News? Drug Launch: Eli Lilly launched donanemab in India under the brand name Lormalzi for Alzheimer’s treatment. First Therapy: It is the first Alzheimer’s disease-modifying therapy commercially launched in India for early-stage patients. High Cost: The treatment costs around ₹91,688 per dose and requires monthly infusions for …
Read MoreSEMAGLUTIDE GENERICS EXPAND INDIA’S GLP-1 DRUG MARKET Why in the News? The launch of generic versions of semaglutide has led to a 75% rise in sales of GLP-1 drugs in India within one month. Sales volume of semaglutide increased from 25,000 units in February to 1.7 lakh units in April 2026 after patent expiry of …
Read MoreNovel Method Revives Antibiotic Effectiveness Against Resistant Bacteria Why in the News ? Researchers from IIT Bombay have developed a novel approach to tackle antimicrobial resistance (AMR) by restoring the effectiveness of existing antibiotics. The innovation uses DNA aptamers and liposomes to disable bacterial resistance mechanisms, offering a breakthrough in infection treatment that aligns with …
Read MoreTO BE FUTURE READY, HEALTHCARE MUST ENSURE QUALITY Syllabus: GS 3: Science and Technology GS 2: Health Why in the News? The Lancet Commission on Reimagining India’s Health System was launched recently, renewing debate on whether India’s healthcare reforms prioritise quality, continuity, and equity, beyond financial coverage, as the country confronts rising non-communicable diseases, mental …
Read MoreIndia’s Neurotechnology Opportunities and Global Progress Why in the News? Growing global advances in neurotechnology, especially Brain-Computer Interface (BCI) systems, have renewed focus on how India can leverage these tools for healthcare, innovation, and bioeconomy expansion. Rising neurological disorders and emerging global regulations make this an urgent national policy priority, similar to how environmental clearances …
Read MoreExperts Push for Recognition of Type 5 Diabetes Why in the News ? Experts have urged the formal classification of “Type 5 Diabetes”, a condition prevalent among underweight young adults in low- and middle-income countries (LMICs). The proposal, called the Vellore Declaration, was endorsed at the International Diabetes Federation (IDF) Congress 2025 and published in …
Read MoreIndia Develops Indigenous Multi-Stage Malaria Vaccine Why in News? India is developing AdFalciVax, a new malaria vaccine candidate targeting Plasmodium falciparum, the deadliest malaria parasite. Spearheaded by ICMR and DBT-NII, it aims to prevent clinical malaria episodes and community transmission, supporting India’s Make in India initiative and malaria elimination strategy. This development marks a significant …
Read More
